Loading...
News 2018-04-27T13:47:37+00:00

News

Number Title Author Date
18
18 January 2018 Bio & Medicine Alteogen to seek US approval for clinical trials of Eylea biosimilar
alteogen | 2018.05.28 | Votes 0 | Views 23
alteogen 2018.05.28
17
23 Aug. 2017 Alteogen set to start phase I trial of ADC product in Korea
alteogen | 2018.05.28 | Votes 0 | Views 16
alteogen 2018.05.28
16
26 APR 2017 Alteogen partners with Cristalia to develop long-acting growth hormone
alteogen | 2018.05.28 | Votes 0 | Views 9
alteogen 2018.05.28
15
20 APR 2017 Alteogen to enter late-stage study of Herceptin biosimilar
alteogen | 2018.05.28 | Votes 0 | Views 8
alteogen 2018.05.28
14
29 MAR 2017 Korean firm to transfer biosimilar tech to Chinese partner
alteogen | 2018.05.28 | Votes 0 | Views 11
alteogen 2018.05.28
13
29 DEC 2016 Alteogen patents
alteogen | 2018.05.28 | Votes 0 | Views 5
alteogen 2018.05.28
12
22 DEC 2016 Alteogen clears phase 1 trial of Herceptin biosimilar in Canada
alteogen | 2018.05.28 | Votes 0 | Views 5
alteogen 2018.05.28
11
7 Oct 2016 Alteogen receives patent in Japan
alteogen | 2018.05.28 | Votes 0 | Views 5
alteogen 2018.05.28
10
7 Mar 2016 Additional N-glycosylation in the N-terminal region of recombinant human alpha-1 antitrypsin enhances the circulator
alteogen | 2018.05.28 | Votes 0 | Views 5
alteogen 2018.05.28
9
24 AUG 2016 Human Phase1 Clinical Data of ALT-P1 (hGH-NexP) by Healthy Korean Males
alteogen | 2018.05.28 | Votes 0 | Views 5
alteogen 2018.05.28